NYSE:CLVT
CLARIVATE PLC
Clarivate provides enterprise-grade data analytics and content services empowering businesses to navigate complex global markets in legal, healthcare, and science industries.
Key Metrics
Investment Thesis
Bull Case
The narrowing net loss trend suggests the company is successfully stabilizing its core operations while retaining a strong cash position with $329.2M in cash equivalents. Clarivate's dominant market position allows it to monetize high-value data assets that competitors cannot replicate, potentially leading to a turnaround once current restructuring costs subside.
Bear Case
The company has posted losses for five consecutive years with revenue declining steadily, raising concerns about the sustainability of its business model in a slowing enterprise software market. With retained earnings deficit exceeding $7.5B and negative cfo-to-net-income ratios, Clarivate faces significant hurdles in returning to consistent profitability without further dilution or asset sales.
About CLARIVATE PLC
Clarivate serves global markets with data-driven solutions including Clarivate Analytics, Wolters Kluwer Health, and ScienceDirect. The company leverages AI-powered tools to help organizations manage intellectual property, conduct market research, and access scientific literature across pharmaceutical, legal, and life sciences sectors.
Analysis
Management Discussion
Despite reducing annual revenue from $2.66B in 2022 to $2.46B in 2025, the company has managed to narrow its net loss significantly from a deficit of $3.96B in 2022 to just $-201.1M last year. However, operating cash flow of $628.5M was partially offset by massive debt repayments of $600M and negative financing cash flows, highlighting aggressive balance sheet restructuring amidst profitability struggles.
Industry Overview
The global data analytics and information services industry is shifting toward AI-integrated platforms that combine primary source content with predictive intelligence. Companies in this space face intense competition from hyperscalers offering free basic datasets, forcing specialized players to focus on deep vertical expertise and proprietary algorithms to maintain pricing power.
Financial Statements
Income Statement
Balance Sheet
Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | $2.66B | $2.63B | $2.56B | $2.46B |
| Cost of Revenue | $954.0M | $906.4M | $869.2M | $833.6M |
| Gross Profit | $1.71B | $1.72B | $1.69B | $1.62B |
| Operating Expenses | $5.63B | $2.46B | $1.96B | $1.55B |
| Operating Income | $-3.93B | $-734.7M | $-275.6M | $71.5M |
| G&A | $729.9M | $739.7M | $727.6M | $708.6M |
| Stock-Based Comp | $93.9M | $109.0M | $59.9M | $63.1M |
| D&A | $710.5M | $708.3M | $727.0M | $757.2M |
| Depreciation | $35.2M | $23.2M | $19.0M | $21.9M |
| Amortization | $675.3M | $685.1M | $708.0M | $735.3M |
| Other OpEx | $4.90B | $1.72B | $1.24B | $841.5M |
| Non-Operating Income | $-63.5M | $-277.8M | $-278.2M | $-265.4M |
| Interest Expense | $270.3M | $293.7M | — | — |
| Pre-Tax Income | $-3.99B | $-1.01B | $-553.8M | $-193.9M |
| Income Tax | $-28.9M | $-101.3M | $82.9M | $7.2M |
| Continuing Ops | $-3.96B | $-911.2M | $-636.7M | $-201.1M |
| Discontinued Ops | $0 | $0 | $0 | $0 |
| Net Income | $-3.96B | $-911.2M | $-636.7M | $-201.1M |
| Minority Interest | $0 | $0 | $0 | $0 |
| Net to Common | $-3.96B | $-911.2M | $-636.7M | $-201.1M |
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Current Assets | $1.40B | $1.46B | $1.24B | $1.31B |
| Cash & Equivalents | $348.8M | $370.7M | $295.2M | $329.2M |
| Accounts Receivable | $872.1M | $908.3M | $798.3M | $821.7M |
| Other Current Assets | $174.3M | $183.2M | $151.1M | $159.1M |
| Long-Term Assets | $12.55B | $11.24B | $10.25B | $9.76B |
| Intangibles | $9.44B | $9.01B | $8.44B | $8.01B |
| Goodwill | $2.88B | $2.02B | $1.57B | $1.57B |
| Operating Leases | $58.9M | $55.2M | $53.6M | $46.6M |
| Other LT Assets | $176.6M | $159.1M | $184.2M | $138.0M |
| Total Assets | $13.94B | $12.71B | $11.49B | $11.07B |
| Current Liabilities | $1.56B | $1.60B | $1.43B | $1.57B |
| Accounts Payable | $101.4M | $144.1M | $124.5M | $150.6M |
| Current Leases | $25.7M | $24.4M | $20.6M | $18.4M |
| Deferred Revenue | $947.5M | $983.1M | $859.1M | $878.6M |
| Other Current Liab | $485.2M | $448.4M | $429.3M | $521.2M |
| Long-Term Liabilities | $5.57B | $5.11B | $4.92B | $4.66B |
| LT Operating Leases | $72.9M | $63.2M | $53.2M | $37.9M |
| Other LT Liab | $5.46B | $5.01B | $4.85B | $4.60B |
| Total Liabilities | $7.13B | $6.71B | $6.35B | $6.23B |
| Shareholders' Equity | $6.81B | $5.99B | $5.14B | $4.84B |
| Retained Earnings | $-5.66B | $-6.65B | $-7.31B | $-7.51B |
| AOCI | $-665.9M | $-495.3M | $-526.3M | $-453.1M |
| Total L&E | $13.94B | $12.71B | $11.49B | $11.07B |
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Net Income (CFO) | $-3.96B | $-911.2M | $-636.7M | $-201.1M |
| Non-Cash Adjustments | $4.56B | $1.72B | $1.51B | $821.8M |
| Working Capital Changes | $-87.3M | $-65.0M | $-227.9M | $7.8M |
| Cash from Operations | $509.3M | $744.2M | $646.6M | $628.5M |
| Capital Expenditures | $202.9M | $242.5M | $289.1M | $263.2M |
| Cash from Investing | $57.3M | $-237.4M | $-236.7M | $-263.2M |
| Debt Issuances | $0 | $0 | — | — |
| Debt Repayments | — | $300.0M | $198.1M | $600.0M |
| Dividends Paid | $75.4M | $75.5M | $37.7M | $0 |
| Cash from Financing | $-759.2M | $-496.5M | $-470.1M | $-343.1M |
| FX Effect | $-38.2M | $3.6M | $-15.3M | $11.8M |
| Net Change in Cash | $-230.8M | $13.9M | $-75.5M | $34.0M |
| Beginning Cash | $587.6M | $356.8M | $370.7M | $295.2M |
| Ending Cash | $356.8M | $370.7M | $295.2M | $329.2M |
Frequently Asked Questions
How does CLARIVATE PLC make money?
Primary revenue streams include Clarivate Analytics for IP management and market intelligence, Wolters Kluwer Health for medical research and clinical trial data, and ScienceDirect providing access to academic journals and primary source content.
What are the main risks for CLVT?
Significant revenue contraction observed over the last three years alongside persistent net losses indicates potential market headwinds or product adoption issues. Heavy reliance on a few large enterprise contracts creates concentration risk, while the substantial accumulated other comprehensive income loss and retained earnings deficit suggest underlying capital efficiency challenges. High amortization expenses tied to $1.57B in goodwill could impact future profitability if acquisitions do not generate expected synergies.
What is CLVT's competitive advantage?
Clarivate possesses an unassailable moat built on a massive proprietary database of over 1 billion documents and its unique AI-driven platforms like PatSnap and SciENcv. The company benefits from high switching costs for enterprise clients who rely on deep historical data integration, creating strong customer retention in lucrative B2B markets.
Related Companies
Not financial advice. All content is for informational purposes only. Data may contain errors. Consult a qualified financial advisor before making investment decisions.